{"id":"https://openalex.org/W3157449636","doi":"https://doi.org/10.3389/fphar.2021.611657","title":"The Cardenolide Glycoside Acovenoside A Interferes with Epidermal Growth Factor Receptor Trafficking in Non-Small Cell Lung Cancer Cells","display_name":"The Cardenolide Glycoside Acovenoside A Interferes with Epidermal Growth Factor Receptor Trafficking in Non-Small Cell Lung Cancer Cells","publication_year":2021,"publication_date":"2021-05-05","ids":{"openalex":"https://openalex.org/W3157449636","doi":"https://doi.org/10.3389/fphar.2021.611657","mag":"3157449636","pmid":"https://pubmed.ncbi.nlm.nih.gov/34025398","pmcid":"https://www.ncbi.nlm.nih.gov/pmc/articles/8133365"},"language":"en","primary_location":{"id":"doi:10.3389/fphar.2021.611657","doi":"https://doi.org/10.3389/fphar.2021.611657","is_oa":true,"landing_page_url":"https://doi.org/10.3389/fphar.2021.611657","pdf_url":"https://www.frontiersin.org/articles/10.3389/fphar.2021.611657/pdf","source":{"id":"https://openalex.org/S132108250","display_name":"Frontiers in Pharmacology","issn_l":"1663-9812","issn":["1663-9812"],"is_oa":true,"is_in_doaj":true,"is_core":true,"listed_in":["cwts-core","doaj","ki-jl-1","norway-1","poland-100","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320527","host_organization_name":"Frontiers Media","host_organization_lineage":["https://openalex.org/P4310320527"],"host_organization_lineage_names":["Frontiers Media"],"type":"journal"},"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Frontiers in Pharmacology","raw_type":"journal-article"},"volume":null,"type":"article","is_traditional":true,"indexed_in":["crossref","datacite","doaj","pubmed"],"open_access":{"is_oa":true,"oa_status":"gold","oa_url":"https://www.frontiersin.org/articles/10.3389/fphar.2021.611657/pdf","any_repository_has_fulltext":true},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5029106160","display_name":"Susanne H\u00e4fner","orcid":"https://orcid.org/0000-0003-0663-8382","observed_orcids":["https://orcid.org/0000-0003-0663-8382"]},"institutions":[{"id":"https://openalex.org/I196349391","display_name":"Universit\u00e4t Ulm","ror":"https://ror.org/032000t02","country_code":"DE","type":"education","lineage":["https://openalex.org/I196349391"]}],"countries":["DE"],"is_corresponding":true,"raw_author_name":"Susanne Hafner","raw_affiliation_strings":["Institute of Pharmacology of Natural Products and Clinical Pharmacology, Ulm University, Ulm, Germany"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Institute of Pharmacology of Natural Products and Clinical Pharmacology, Ulm University, Ulm, Germany","institution_ids":["https://openalex.org/I196349391"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5049154227","display_name":"Michael Schmiech","orcid":"https://orcid.org/0000-0003-4350-0331","observed_orcids":["https://orcid.org/0000-0003-4350-0331"]},"institutions":[{"id":"https://openalex.org/I196349391","display_name":"Universit\u00e4t Ulm","ror":"https://ror.org/032000t02","country_code":"DE","type":"education","lineage":["https://openalex.org/I196349391"]}],"countries":["DE"],"is_corresponding":false,"raw_author_name":"Michael Schmiech","raw_affiliation_strings":["Institute of Pharmacology of Natural Products and Clinical Pharmacology, Ulm University, Ulm, Germany"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Institute of Pharmacology of Natural Products and Clinical Pharmacology, Ulm University, Ulm, Germany","institution_ids":["https://openalex.org/I196349391"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5103947651","display_name":"Sophia Johanna Lang","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I196349391","display_name":"Universit\u00e4t Ulm","ror":"https://ror.org/032000t02","country_code":"DE","type":"education","lineage":["https://openalex.org/I196349391"]}],"countries":["DE"],"is_corresponding":false,"raw_author_name":"Sophia Johanna Lang","raw_affiliation_strings":["Institute of Pharmacology of Natural Products and Clinical Pharmacology, Ulm University, Ulm, Germany"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Institute of Pharmacology of Natural Products and Clinical Pharmacology, Ulm University, Ulm, Germany","institution_ids":["https://openalex.org/I196349391"]}]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":1,"corresponding_author_ids":["https://openalex.org/A5029106160"],"corresponding_institution_ids":["https://openalex.org/I196349391"],"apc_list":{"value":2950,"currency":"USD","value_usd":2950},"apc_paid":{"value":1984,"currency":"EUR","value_usd":2139},"fwci":0.5933,"has_fulltext":true,"cited_by_count":18,"citation_normalized_percentile":{"value":0.50200938,"is_in_top_1_percent":false,"is_in_top_10_percent":false},"cited_by_percentile_year":{"min":87,"max":98},"biblio":{"volume":"12","issue":null,"first_page":"611657","last_page":"611657"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T13185","display_name":"Phytochemistry and Bioactive Compounds","score":0.5116999745368958,"subfield":{"id":"https://openalex.org/subfields/2502","display_name":"Biomaterials"},"field":{"id":"https://openalex.org/fields/25","display_name":"Materials Science"},"domain":{"id":"https://openalex.org/domains/3","display_name":"Physical Sciences"}},"topics":[{"id":"https://openalex.org/T13185","display_name":"Phytochemistry and Bioactive Compounds","score":0.5116999745368958,"subfield":{"id":"https://openalex.org/subfields/2502","display_name":"Biomaterials"},"field":{"id":"https://openalex.org/fields/25","display_name":"Materials Science"},"domain":{"id":"https://openalex.org/domains/3","display_name":"Physical Sciences"}},{"id":"https://openalex.org/T10755","display_name":"HER2/EGFR in Cancer Research","score":0.149399995803833,"subfield":{"id":"https://openalex.org/subfields/2730","display_name":"Oncology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10724","display_name":"Ion Transport and Channel Regulation","score":0.09030000120401382,"subfield":{"id":"https://openalex.org/subfields/1312","display_name":"Molecular Biology"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/cardenolides","display_name":"cardenolides","score":0.9980000257492065},{"id":"https://openalex.org/keywords/non-small-cell-lung-cancer","display_name":"non-small cell lung cancer","score":0.8610000014305115},{"id":"https://openalex.org/keywords/epidermal-growth-factor-receptor","display_name":"epidermal growth factor receptor","score":0.8870000243186951},{"id":"https://openalex.org/keywords/egfr-trafficking","display_name":"EGFR trafficking","score":0.8970000147819519},{"id":"https://openalex.org/keywords/na-k-atpase-inhibition","display_name":"Na+/K+-ATPase inhibition","score":0.9020000100135803},{"id":"https://openalex.org/keywords/src-kinase","display_name":"Src kinase","score":0.7540000081062317},{"id":"https://openalex.org/keywords/nf-kappab-activation","display_name":"NF-\u03baB activation","score":0.8330000042915344},{"id":"https://openalex.org/keywords/apoptosis","display_name":"apoptosis","score":0.9620000123977661},{"id":"https://openalex.org/keywords/egfr-ubiquitination","display_name":"EGFR ubiquitination","score":0.7620000243186951},{"id":"https://openalex.org/keywords/intracellular-sodium","display_name":"intracellular sodium","score":0.8479999899864197},{"id":"https://openalex.org/keywords/atp-depletion","display_name":"ATP depletion","score":0.5070000290870667},{"id":"https://openalex.org/keywords/egfr-mutation","display_name":"EGFR mutation","score":0.47099998593330383},{"id":"https://openalex.org/keywords/xenograft-models","display_name":"xenograft models","score":0.4819999933242798}],"concepts":[{"id":"https://openalex.org/C2780257055","wikidata":"https://www.wikidata.org/wiki/Q423910","display_name":"Cardenolide","level":3,"score":0.8356373906135559},{"id":"https://openalex.org/C2779438470","wikidata":"https://www.wikidata.org/wiki/Q424401","display_name":"Epidermal growth factor receptor","level":3,"score":0.5858311653137207},{"id":"https://openalex.org/C2779133857","wikidata":"https://www.wikidata.org/wiki/Q285911","display_name":"Ouabain","level":3,"score":0.5119801759719849},{"id":"https://openalex.org/C108636557","wikidata":"https://www.wikidata.org/wiki/Q21109354","display_name":"Proto-oncogene tyrosine-protein kinase Src","level":3,"score":0.4983217716217041},{"id":"https://openalex.org/C2776362946","wikidata":"https://www.wikidata.org/wiki/Q424374","display_name":"Epidermal growth factor","level":3,"score":0.46704524755477905},{"id":"https://openalex.org/C96232424","wikidata":"https://www.wikidata.org/wiki/Q4118072","display_name":"Cancer cell","level":3,"score":0.4526115357875824},{"id":"https://openalex.org/C185592680","wikidata":"https://www.wikidata.org/wiki/Q2329","display_name":"Chemistry","level":0,"score":0.44946107268333435},{"id":"https://openalex.org/C81729549","wikidata":"https://www.wikidata.org/wiki/Q4649475","display_name":"A549 cell","level":3,"score":0.42601561546325684},{"id":"https://openalex.org/C95444343","wikidata":"https://www.wikidata.org/wiki/Q7141","display_name":"Cell biology","level":1,"score":0.4253257215023041},{"id":"https://openalex.org/C184235292","wikidata":"https://www.wikidata.org/wiki/Q421851","display_name":"Kinase","level":2,"score":0.40330934524536133},{"id":"https://openalex.org/C86803240","wikidata":"https://www.wikidata.org/wiki/Q420","display_name":"Biology","level":0,"score":0.38845330476760864},{"id":"https://openalex.org/C55493867","wikidata":"https://www.wikidata.org/wiki/Q7094","display_name":"Biochemistry","level":1,"score":0.31975746154785156},{"id":"https://openalex.org/C190283241","wikidata":"https://www.wikidata.org/wiki/Q14599311","display_name":"Apoptosis","level":2,"score":0.2929942011833191},{"id":"https://openalex.org/C194671627","wikidata":"https://www.wikidata.org/wiki/Q192639","display_name":"Glycoside","level":2,"score":0.27159324288368225},{"id":"https://openalex.org/C170493617","wikidata":"https://www.wikidata.org/wiki/Q208467","display_name":"Receptor","level":2,"score":0.23420852422714233},{"id":"https://openalex.org/C121608353","wikidata":"https://www.wikidata.org/wiki/Q12078","display_name":"Cancer","level":2,"score":0.219166100025177},{"id":"https://openalex.org/C537181965","wikidata":"https://www.wikidata.org/wiki/Q658","display_name":"Sodium","level":2,"score":0.061144620180130005},{"id":"https://openalex.org/C178790620","wikidata":"https://www.wikidata.org/wiki/Q11351","display_name":"Organic chemistry","level":1,"score":0.0},{"id":"https://openalex.org/C54355233","wikidata":"https://www.wikidata.org/wiki/Q7162","display_name":"Genetics","level":1,"score":0.0}],"mesh":[],"locations_count":6,"locations":[{"id":"doi:10.3389/fphar.2021.611657","doi":"https://doi.org/10.3389/fphar.2021.611657","is_oa":true,"landing_page_url":"https://doi.org/10.3389/fphar.2021.611657","pdf_url":"https://www.frontiersin.org/articles/10.3389/fphar.2021.611657/pdf","source":{"id":"https://openalex.org/S132108250","display_name":"Frontiers in Pharmacology","issn_l":"1663-9812","issn":["1663-9812"],"is_oa":true,"is_in_doaj":true,"is_core":true,"listed_in":["cwts-core","doaj","ki-jl-1","norway-1","poland-100","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320527","host_organization_name":"Frontiers Media","host_organization_lineage":["https://openalex.org/P4310320527"],"host_organization_lineage_names":["Frontiers Media"],"type":"journal"},"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Frontiers in Pharmacology","raw_type":"journal-article"},{"id":"pmh:oai:pubmedcentral.nih.gov:8133365","doi":null,"is_oa":true,"landing_page_url":"https://www.ncbi.nlm.nih.gov/pmc/articles/8133365","pdf_url":"https://pmc.ncbi.nlm.nih.gov/articles/PMC8133365/pdf/fphar-12-611657.pdf","source":{"id":"https://openalex.org/S2764455111","display_name":"PubMed Central","issn_l":null,"issn":null,"is_oa":true,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Front Pharmacol","raw_type":"Text"},{"id":"pmid:34025398","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/34025398","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Frontiers in pharmacology","raw_type":"Journal Article"},{"id":"pmh:oai:doaj.org/article:a02b39a04ab5467eab29fb47041e74f6","doi":null,"is_oa":true,"landing_page_url":"https://doaj.org/article/a02b39a04ab5467eab29fb47041e74f6","pdf_url":null,"source":{"id":"https://openalex.org/S4306401280","display_name":"DOAJ (DOAJ: Directory of Open Access Journals)","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":null,"host_organization_name":null,"host_organization_lineage":[],"host_organization_lineage_names":[],"type":"repository"},"license":"cc-by-sa","license_id":"https://openalex.org/licenses/cc-by-sa","version":"submittedVersion","is_accepted":false,"is_published":false,"raw_source_name":"Frontiers in Pharmacology, Vol 12 (2021)","raw_type":"article"},{"id":"pmh:oai:oparu.uni-ulm.de:123456789/39557","doi":null,"is_oa":true,"landing_page_url":"http://nbn-resolving.de/urn:nbn:de:bsz:289-oparu-39557-8","pdf_url":null,"source":{"id":"https://openalex.org/S4306400353","display_name":"OPen Access Repositorium der Universit\u00e4t Ulm (OPARU) (Ulm University)","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I196349391","host_organization_name":"Universit\u00e4t Ulm","host_organization_lineage":["https://openalex.org/I196349391"],"host_organization_lineage_names":[],"type":"repository"},"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"submittedVersion","is_accepted":false,"is_published":false,"raw_source_name":null,"raw_type":"doc-type:article"},{"id":"doi:10.18725/oparu-39481","doi":"https://doi.org/10.18725/oparu-39481","is_oa":true,"landing_page_url":"https://doi.org/10.18725/oparu-39481","pdf_url":null,"source":{"id":"https://openalex.org/S7407052964","display_name":"Universit\u00e4t Ulm, Kommunikations- und Informationszentrum (kiz)","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":null,"host_organization_name":null,"host_organization_lineage":[],"host_organization_lineage_names":[],"type":"repository"},"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":null,"is_accepted":false,"is_published":false,"raw_source_name":null,"raw_type":"Other"}],"best_oa_location":{"id":"doi:10.3389/fphar.2021.611657","doi":"https://doi.org/10.3389/fphar.2021.611657","is_oa":true,"landing_page_url":"https://doi.org/10.3389/fphar.2021.611657","pdf_url":"https://www.frontiersin.org/articles/10.3389/fphar.2021.611657/pdf","source":{"id":"https://openalex.org/S132108250","display_name":"Frontiers in Pharmacology","issn_l":"1663-9812","issn":["1663-9812"],"is_oa":true,"is_in_doaj":true,"is_core":true,"listed_in":["cwts-core","doaj","ki-jl-1","norway-1","poland-100","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320527","host_organization_name":"Frontiers Media","host_organization_lineage":["https://openalex.org/P4310320527"],"host_organization_lineage_names":["Frontiers Media"],"type":"journal"},"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Frontiers in Pharmacology","raw_type":"journal-article"},"sustainable_development_goals":[{"display_name":"Good health and well-being","score":0.98580002784729,"id":"https://metadata.un.org/sdg/3"}],"study_designs":[],"awards":[],"funders":[],"has_content":{"grobid_xml":true,"pdf":true},"content_urls":{"pdf":"https://content.openalex.org/works/W3157449636.pdf","grobid_xml":"https://content.openalex.org/works/W3157449636.grobid-xml"},"referenced_works_count":61,"referenced_works":["https://openalex.org/W1548298803","https://openalex.org/W1594203091","https://openalex.org/W1932580670","https://openalex.org/W1977371829","https://openalex.org/W1979129905","https://openalex.org/W1982572987","https://openalex.org/W1991716304","https://openalex.org/W2003834810","https://openalex.org/W2004631970","https://openalex.org/W2007210021","https://openalex.org/W2014899206","https://openalex.org/W2017291180","https://openalex.org/W2026306187","https://openalex.org/W2027840561","https://openalex.org/W2037793441","https://openalex.org/W2043696829","https://openalex.org/W2054405945","https://openalex.org/W2068125497","https://openalex.org/W2069471870","https://openalex.org/W2070358111","https://openalex.org/W2081161751","https://openalex.org/W2085263133","https://openalex.org/W2089378397","https://openalex.org/W2095289484","https://openalex.org/W2099686861","https://openalex.org/W2104257202","https://openalex.org/W2106820689","https://openalex.org/W2108205327","https://openalex.org/W2122252852","https://openalex.org/W2140529908","https://openalex.org/W2141112224","https://openalex.org/W2154044374","https://openalex.org/W2154392149","https://openalex.org/W2160600815","https://openalex.org/W2161336797","https://openalex.org/W2163882233","https://openalex.org/W2169204725","https://openalex.org/W2172287945","https://openalex.org/W2174844940","https://openalex.org/W2222658859","https://openalex.org/W2255416290","https://openalex.org/W2265104901","https://openalex.org/W2326136111","https://openalex.org/W2397911846","https://openalex.org/W2403348805","https://openalex.org/W2404883931","https://openalex.org/W2411449916","https://openalex.org/W2427094903","https://openalex.org/W2488829406","https://openalex.org/W2514872395","https://openalex.org/W2537623931","https://openalex.org/W2593436234","https://openalex.org/W2606368128","https://openalex.org/W2734619127","https://openalex.org/W2735251791","https://openalex.org/W2767707410","https://openalex.org/W2773778202","https://openalex.org/W2794254026","https://openalex.org/W2946765204","https://openalex.org/W2954926994","https://openalex.org/W2981220896"],"related_works":["https://openalex.org/W4389021877","https://openalex.org/W2773778202","https://openalex.org/W2587009424","https://openalex.org/W4392560114","https://openalex.org/W4231489713","https://openalex.org/W2808680713","https://openalex.org/W2767488254","https://openalex.org/W2182288708","https://openalex.org/W3121155599","https://openalex.org/W4384501821"],"abstract_inverted_index":{"Cardenolide":[0,316],"glycosides":[1,216,317],"are":[2,23],"natural":[3],"compounds":[4],"known":[5,285],"to":[6,26,40,56,134,189,208,258,279],"inhibit":[7,318],"the":[8,13,32,69,74,120,136,185,212,280,304,314,319,324,344],"ion":[9,70],"pumping":[10,71],"function":[11,72],"of":[12,73,111,122,179,192,268,287],"Na+/K+-ATPase":[14,76,140,325],"in":[15,95,104,107,160,165,194,219,270,327],"cellular":[16],"systems.":[17],"Interestingly,":[18],"various":[19],"cancer":[20,49,197],"cell":[21,47,93,198],"types":[22],"highly":[24],"susceptible":[25],"cardenolide":[27,33,195,215],"glycosides.":[28],"Herein,":[29],"we":[30,153,221,247],"explore":[31],"glycoside":[34],"Acovenoside":[35],"A":[36],"(AcoA)":[37],"with":[38,241,252,262,313],"respect":[39],"its":[41,310],"influences":[42],"on":[43,115],"human":[44],"A549":[45,161,249],"non-small":[46],"lung":[48],"(NSCLC)":[50],"cells.":[51,97],"We":[52,132],"found":[53,154],"that":[54,68,155,337],"exposure":[55],"AcoA,":[57],"digoxin":[58,81,265],"and":[59,64,82,90,126,146,181,217,228,264,297],"ouabain":[60],"increases":[61],"intracellular":[62,329],"sodium":[63],"ATP":[65],"levels":[66],"indicating":[67],"transmembrane":[75,141],"is":[77,175,301],"effectively":[78],"inhibited.":[79],"Like":[80],"ouabain,":[83],"AcoA":[84,109,156,263],"inhibits":[85],"transcription":[86],"factor":[87,149],"NF-\u03baB":[88],"activation":[89],"induces":[91],"apoptotic":[92,128],"death":[94],"NSCLC":[96,112,201],"This":[98],"was":[99],"confirmed":[100],"by":[101,303],"a":[102,166,176,190,253,284],"preclinical":[103],"vivo":[105],"model":[106],"which":[108,256,306],"treatment":[110],"xenografts":[113],"grown":[114],"chick":[116],"chorioallantoic":[117],"membranes":[118],"inhibited":[119],"expression":[121],"proliferation":[123],"antigen":[124],"Ki-67":[125],"induced":[127,266],"DNA":[129],"strand":[130],"breaks.":[131],"aimed":[133],"elucidate":[135],"underlying":[137],"mechanisms.":[138],"The":[139],"complex":[142],"contains":[143],"Src":[144,158,171,173],"kinase":[145,159,174],"epidermal":[147],"growth":[148],"receptor":[150],"(EGFR).":[151],"Indeed,":[152],"activates":[157],"cells,":[162],"but":[163],"not":[164,232],"cell-free":[167],"assay":[168],"using":[169,184],"recombinant":[170],"kinase.":[172],"downstream":[177],"target":[178],"EGFR,":[180],"correlation":[182],"analysis":[183],"NCI60":[186],"database":[187],"pointed":[188],"role":[191],"EGFR":[193,218,229,236,245,269,276,288,295,341],"glycoside-induced":[196],"death.":[199],"Accordingly,":[200],"cells":[202,250],"expressing":[203],"hyperphosphorylated":[204],"EGFRmut":[205],"exhibited":[206],"resistance":[207],"AcoA.":[209,242],"To":[210,243],"investigate":[211],"interaction":[213,312],"between":[214],"detail,":[220],"performed":[222],"immunoblotting":[223],"studies:":[224],"Whereas":[225],"ligand":[226],"binding":[227],"phosphorylation":[230],"were":[231],"significantly":[233],"affected,":[234],"ubiquitinated":[235],"accumulated":[237],"after":[238],"prolonged":[239],"incubation":[240],"visualize":[244],"trafficking":[246,296,342],"used":[248],"transfected":[251],"fluorescent":[254],"biosensor":[255],"binds":[257],"activated":[259],"EGFR.":[260,315],"Pretreatment":[261],"accumulation":[267],"endosomal":[271,289,345],"compartments":[272],"thus":[273],"inhibiting":[274],"EGF-induced":[275],"degradation":[277],"comparable":[278],"Na+":[281,292,299,330],"ionophore":[282],"monensin,":[283],"inducer":[286],"arrest.":[290],"Intracellular":[291],"concentrations":[293],"regulate":[294],"signaling.":[298],"homeostasis":[300],"maintained":[302],"Na+/K+-ATPase,":[305],"might":[307],"account":[308],"for":[309],"close":[311],"ATP-dependent":[320],"Na+/K+":[321],"exchange":[322],"through":[323],"resulting":[326],"higher":[328],"levels.":[331],"Our":[332],"data":[333],"provide":[334],"first":[335],"evidence":[336],"this":[338],"impedes":[339],"efficient":[340],"at":[343],"compartment.":[346]},"counts_by_year":[{"year":2026,"cited_by_count":3},{"year":2025,"cited_by_count":5},{"year":2024,"cited_by_count":5},{"year":2023,"cited_by_count":4},{"year":2021,"cited_by_count":1}],"updated_date":"2026-11-07T11:25:07.637180","created_date":"2021-05-10T00:00:00"}